Elevated Levels of the Endosomal‐Lysosomal Proteinase Cathepsin D in Cerebrospinal Fluid in Alzheimer Disease

Cathepsin D—Many functions of one aspartic protease

Beneš, P., Větvička, V., & Fusek, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.008 · Cited by 640 · see citing works

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease

Goetzl, E. J., Boxer, A. L., Schwartz, J. B., Abner, E. L., Petersen, R. C., Miller, B. L., & Kapogiannis, D. (2015) · Neurology · doi:10.1212/wnl.0000000000001702 · Cited by 466 · see citing works

The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review

Nixon, R., Cataldo, A., & Mathews, P. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 332 · see citing works

Presenilin-1, Nicastrin, Amyloid Precursor Protein, and γ-Secretase Activity Are Co-localized in the Lysosomal Membrane

Pasternak, S., Bagshaw, R. D., Guiral, M., Zhang, S., Ackerley, C. A., Pak, B. J., Callahan, J. W., & Mahuran, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304009200 · Cited by 314 · see citing works

Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease

Arai, H., Terajima, M., Miura, M., Higuchi, S., Muramatsu, T., Machida, N., Seiki, H., Takase, S., Clark, C., Lee, V. M., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380414 · Cited by 314 · see citing works

Autophagy in neurons: a review.

Larsen, K. E., & Sulzer, D. L. (2002) · PubMed · doi:10.14670/hh-17.897 · Cited by 242 · see citing works

Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme

MCDERMOTT, J. R., & GIBSON, A. M. (1997) · Neurochemical Research · doi:10.1023/a:1027325304203 · Cited by 184 · see citing works

Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links

Moors, T. E., Paciotti, S., Chiasserini, D., Calabresi, P., Parnetti, L., Beccari, T., & van de Berg, W. D. J. (2016) · Movement Disorders · doi:10.1002/mds.26562 · Cited by 175 · see citing works

Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)

Jiang, Y., Sato, Y., Im, E., Berg, M., Bordi, M., Darji, S., Kumar, A., Mohan, P. S., Bandyopadhyay, U., Diaz, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0578-19.2019 · Cited by 166 · see citing works

Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice

Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., & Duyckaerts, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63405-0 · Cited by 165 · see citing works

The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders

Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164 · see citing works

Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer’s Disease

Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167 · see citing works

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease

Karayel, Ö., Winter, S. V., Padmanabhan, S., Kuras, Y. I., Vu, D. T., Tuncali, I., Merchant, K., Wills, A.-M. A., Scherzer, C. R., & Mann, M. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100661 · Cited by 158 · see citing works

Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?

Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150 · see citing works

The role of the endosomal/ lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: Reexamining the spatial paradox from a lysosomal perspective

Pasternak, S., Callahan, J., & Mahuran, D. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6107 · Cited by 129 · see citing works

Genome-scale metabolic network reconstruction of model animals as a platform for translational research

Wang, H., Robinson, J. L., Kocabaş, P., Gustafsson, J., Anton, M., Cholley, P., Huang, S., Gobom, J., Svensson, T., Uhlén, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102344118 · Cited by 113 · see citing works

Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease

Armstrong, A., Mattsson, N., Appelqvist, H., Janefjord, C., Sandin, L., Agholme, L., Olsson, B., Svensson, S., Blennow, K., Zetterberg, H., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8269-3 · Cited by 111 · see citing works

The neuronal endosomal-lysosomal system in Alzheimer's disease

Nixon, R. A., Mathews, P. M., & Cataldo, A. M. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3114 · Cited by 111 · see citing works

Reconsider Alzheimer's disease by the ‘calpain–cathepsin hypothesis’—A perspective review

Yamashima, T. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.004 · Cited by 107 · see citing works

Alzheimer's Disease-related Overexpression of the Cation-dependent Mannose 6-Phosphate Receptor Increases Aβ Secretion

Mathews, P. M., Guerra, C. B., Jiang, Y., Grbovic, O. M., Kao, B. H., Schmidt, S. D., Dinakar, R., Mercken, M. H., Hille‐Rehfeld, A., Rohrer, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108161200 · Cited by 103 · see citing works

Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D

Säftig, P., Peters, C., FIGURA, K. V., Craessaerts, K., LEUVEN, F. V., & Strooper, B. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27241 · Cited by 95 · see citing works

Identification of post‐mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration

Lescuyer, P., Allard, L., Zimmermann‐Ivol, C. G., Burgess, J., Frutiger, S., Burkhard, P. R., Sanchez, J., & Hochstrasser, D. F. (2004) · PROTEOMICS · doi:10.1002/pmic.200300822 · Cited by 96 · see citing works

Microarray expression analysis and identification of serum biomarkers for Niemann–Pick disease, type C1

Cluzeau, C. V. M., Watkins‐Chow, D. E., Fu, R., Borate, B. R., Yanjanin, N. M., Dail, M. K., Davidson, C. D., Walkley, S. U., Ory, D. S., Wassif, C. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds193 · Cited by 93 · see citing works

The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches.

Drobny, A., Huarcaya, S. P., Dobert, J., Kluge, A., Bunk, J., Schlothauer, T., & Zunke, F. (2022) · Biochimica et biophysica acta. Molecular cell research · doi:10.1016/j.bbamcr.2022.119243 · Cited by 86 · see citing works

Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration

Peng, W., Minakaki, G., Nguyen, M., & Krainc, D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00742-3 · Cited by 79 · see citing works

The role of Alzheimer's disease risk genes in endolysosomal pathways

Szabo, M. P., Mishra, S., Knupp, A., & Young, J. E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105576 · Cited by 81 · see citing works

Exosome Production Is Key to Neuronal Endosomal Pathway Integrity in Neurodegenerative Diseases

Mathews, P., & Levy, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01347 · Cited by 73 · see citing works

Cathepsin D displays in vitro β-secretase-like specificity

Chevallier, N., Vizzavona, J., Marambaud, P., Baur, C.-P., Spillantini, M. G., Fulcrand, P., Martínez, J., Goedert, M., Vincent, J., & Checler, F. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01330-3 · Cited by 78 · see citing works

Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review

Chen, L., Liu, W., Lin, H., Lin, M., Yu, Y., Liu, H., Dai, Y., Chen, L.-W., Jia, W., He, X., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335832 · Cited by 74 · see citing works

The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease

Bernstein, H., Kirschke, H., Wiederanders, B., Kh, P., Zipress, A., & Rinne, A. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815106 · Cited by 70 · see citing works

Autophagy Modulation as a Treatment of Amyloid Diseases

Mputhia, Z., Hone, E., Tripathi, T., Sargeant, T. J., Martins, R. N., & Bharadwaj, P. (2019) · Molecules · doi:10.3390/molecules24183372 · Cited by 69 · see citing works

Cathepsin D expression is decreased in Alzheimer's disease fibroblasts

Urbanelli, L., Emiliani, C., Massini, C., Persichetti, E., Orlacchio, A., Pelicci, G., Sorbi, S., Hasilík, A., Bernardi, G., & Orlacchio, A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.005 · Cited by 64 · see citing works

Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration

Soreghan, B. A., Thomas, S. N., & Yang, A. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.007 · Cited by 62 · see citing works

Differential expression of cathepsin X in aging and pathological central nervous system of mice

Wendt, W., Zhu, X., Lübbert, H., & Stichel, C. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.007 · Cited by 62 · see citing works

Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease

Helmfors, L., Boman, A., Civitelli, L., Nath, S., Sandin, L., Janefjord, C., McCann, H., Zetterberg, H., Blennow, K., Halliday, G. M., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.024 · Cited by 61 · see citing works

Cathepsin D gene and the risk of Alzheimer's disease: A population-based study and meta-analysis

Schuur, M., Ikram, M. A., Swieten, J. C. V., Isaacs, A. J., Vergeer, J. M., Albert Hofman, D., Oostra, B. A., Breteler, M. M. B., & van Duijn, C. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.011 · Cited by 60 · see citing works

Hippocampal Endosomal, Lysosomal, and Autophagic Dysregulation in Mild Cognitive Impairment

Perez, S. E., He, B., Nadeem, M., Wuu, J., Ginsberg, S. D., Ikonomović, M. D., & Mufson, E. J. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000179 · Cited by 57 · see citing works

Lysosomal Protease Inhibitors Induce Meganeurites and Tangle-like Structures in Entorhinohippocampal Regions Vulnerable to Alzheimer's Disease

Bi, X., Zhou, J., & LYNCH, G. S. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7087 · Cited by 57 · see citing works

Potential neurotoxic activity of diverse molecules released by microglia

Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105117 · Cited by 56 · see citing works

Differential protein expression in diverse brain areas of Parkinson’s and Alzheimer’s disease patients

Esteves, A. R., & Cardoso, S. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70174-z · Cited by 55 · see citing works

Relevance of Autophagy and Mitophagy Dynamics and Markers in Neurodegenerative Diseases

Giorgi, C., Bouhamida, E., Danese, A., Previati, M., Pinton, P., & Patergnani, S. (2021) · Biomedicines · doi:10.3390/biomedicines9020149 · Cited by 50 · see citing works

A paramagnetic chemical exchange-based MRI probe metabolized by cathepsin D: design, synthesis and cellular uptake studies

Suchý, M., Ta, R. M., Li, A. X., Wojciechowski, F., Pasternak, S., Bartha, R., & Hudson, R. H. E. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/b926639a · Cited by 47 · see citing works

Predominant Release of Lysosomal Enzymes by Newborn Rat Microglia After LPS Treatment Revealed by Proteomic Studies

Liu, J., Hong, Z., Ding, J., Liu, J., Zhang, J., & Chen, S. (2008) · Journal of Proteome Research · doi:10.1021/pr7007779 · Cited by 41 · see citing works

Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients

Bjorkli, C., Sandvig, A., & Sandvig, I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00272 · Cited by 41 · see citing works

Identification of Cathepsin D as a Plasma Biomarker for Alzheimer’s Disease

Kim, J.-W., Jung, S.-Y., Kim, Y., Heo, H., Hong, C., Seo, S.-W., Choi, S.-H., Son, S., Lee, S., & Chang, J. (2021) · Cells · doi:10.3390/cells10010138 · Cited by 40 · see citing works

Proteolytic degradation of hemoglobin by endogenous lysosomal proteases gives rise to bioactive peptides: hemorphins

Fruitier‐Arnaudin, I., Garreau-Balandier, I., Lacroix, A., Cupo, A., & Piot, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00271-9 · Cited by 40 · see citing works

Proteome analysis of cerebrospinal fluid in Guillain–Barré syndrome (GBS)

Lehmensiek, V., Süßmuth, S. D., Brettschneider, J., Tauscher, G., Felk, S., Gillardon, F., & Tumani, H. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.01.022 · Cited by 38 · see citing works

Abnormalities of the Endosomal-Lysomal System in Alzheimer’s disease

Cataldo, A. M., Hamilton, D. J., Barnett, J. L., Paskevich, P. A., & Nixon, R. A. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0335-0_34 · Cited by 37 · see citing works

Lysosomes and Brain Aging in Mammals

LYNCH, G. S., & Bi, X. (2003) · Neurochemical Research · doi:10.1023/a:1026069223763 · Cited by 36 · see citing works

Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects

Maarouf, C. L., Andacht, T. M., Kokjohn, T. A., Castaño, E. M., Sue, L. I., Beach, T. G., & Roher, A. E. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929318 · Cited by 34 · see citing works

The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain

Sims‐Robinson, C., Bakeman, A., Rosko, A. J., Glasser, R., & Feldman, E. L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9207-1 · Cited by 33 · see citing works

Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients

Pitto, M., Raimondo, F., Zoia, C., Brighina, L., Ferrarese, C., & Masserini, M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.006 · Cited by 31 · see citing works

The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease

Riemenschneider, M. J., Blennow, K., Wagenpfeil, S., Andreasen, N., Prince, J. A., Laws, S. M., Förstl, H., & Kurz, A. (2006) · Human Mutation · doi:10.1002/humu.20326 · Cited by 30 · see citing works

Elevated Levels of Tau in Cerebrospinal Fluid: Implications for the Antemortem Diagnosis of Alzheimer's Disease

Trojanowski, J. Q., Clark, C. M., Arai, H., & Lee, V. M. ‐. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-510 · Cited by 30 · see citing works

Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β‐amyloid‐toxicity

Wang, Y., Wu, Q., Anand, B. G., Karthivashan, G., Phukan, G., Yang, J., Thinakaran, G., Westaway, D. A., & Kar, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12647 · Cited by 28 · see citing works

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer’s Disease

Liu, X., Baxley, S., Hebron, M. L., Turner, R. S., & Moussa, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115044 · Cited by 29 · see citing works

Lysosomal peptidases—intriguing roles in cancer progression and neurodegeneration

Kos, J., Mitrović, A., Nanut, M. P., & Pišlar, A. H. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13372 · Cited by 28 · see citing works

Gene Expression of Proteases and Protease Inhibitors in the Human Ciliary Epithelium and ODM-2 Cells

Ortego, J., Escribano, J., & Coca‐Prados, M. (1997) · Experimental Eye Research · doi:10.1006/exer.1997.0333 · Cited by 28 · see citing works

The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia

Mishra, S., Morshed, N., Sidhu, S. B., Kinoshita, C., Stevens, B., Jayadev, S., & Young, J. E. (2025) · Glia · doi:10.1002/glia.70009 · Cited by 29 · see citing works

Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid

Persichetti, E., Chiasserini, D., Parnetti, L., Eusebi, P., Paciotti, S., Carlo, C. D., Codini, M., Tambasco, N., Rossi, A., El‐Agnaf, O. M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101453 · Cited by 27 · see citing works

Pleiotropic Effects of Cathepsin D

Vashishta, A., Ohri, S. S., & Větvička, V. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009789839174 · Cited by 25 · see citing works

β-Amyloid increases cathepsin D levels in hippocampus

Hoffman, K. B., Bi, X., Pham, J. T., & LYNCH, G. S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00364-4 · Cited by 25 · see citing works

Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome.

Botté, A., & Potier, M. (2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2019.10.002 · Cited by 20 · see citing works

Non-replication of association between cathepsin D genotype and late onset Alzheimer disease

Menzer, G., Müller‐Thomsen, T., Meins, W., Alberici, A., Binetti, G. G., Höck, C., Nitsch, R. M., Stoppe, G., Reiss, J., & Finckh, U. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1204 · Cited by 24 · see citing works

Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies

Paciotti, S., Gatticchi, L., Beccari, T., & Parnetti, L. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.03.1627 · Cited by 23 · see citing works

Antenatal betamethasone exposure is associated with lower ANG-(1–7) and increased ACE in the CSF of adult sheep

Marshall, A. C., Shaltout, H. A., Pirro, N. T., Rose, J. C., Diz, D. I., & Chappell, M. C. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00321.2013 · Cited by 22 · see citing works

Neuropeptide Y ( NPY ) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY 1–30fragment

Wagner, L., Björkqvist, M., Lundh, S. H., Wolf, R., Börgel, A., Schlenzig, D., Ludwig, H., Rahfeld, J., Leavitt, B. R., Demuth, H., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13624 · Cited by 21 · see citing works

Link between neurodegeneration and trabecular meshwork injury in glaucomatous patients

Zhang, Y., Yang, Q., Guo, F., Chen, X., & Xie, L. (2017) · BMC Ophthalmology · doi:10.1186/s12886-017-0623-z · Cited by 20 · see citing works

A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin‐D detection

Ta, R. M., Suchý, M., Tam, J. H. K., Li, A. X., Martínez‐Santiesteban, F., Scholl, T. J., Hudson, R. H. E., Bartha, R., & Pasternak, S. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1502 · Cited by 17 · see citing works

Lysosomal Dysfunction Reduces Brain-Derived Neurotrophic Factor Expression

Bednarski, E., Lauterborn, J. C., Gall, C. M., & LYNCH, G. S. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6747 · Cited by 16 · see citing works

Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP / PS 1 transgenic mice

Cheng, S., Wani, W. Y., Hottman, D. A., Jeong, A., Cao, D., LeBlanc, K. J., Säftig, P., Zhang, J., & Li, L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14048 · Cited by 15 · see citing works

Expression and characterization of human β-secretase candidates metalloendopeptidase MP78 and cathepsin D in βAPP-overexpressing cells

Thompson, A., Grueninger‐Leitch, F., Huber, G., & Malherbe, P. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00091-0 · Cited by 15 · see citing works

Isoform- and cell-state-specific APOE homeostasis and function

Lindner, K., & Gavin, A.-C. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01470 · Cited by 13 · see citing works

Targeted proteolytic products of τ and α-synuclein in neurodegeneration

Xia, Y., Lloyd, G. M., & Giasson, B. I. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210028 · Cited by 13 · see citing works

Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer’s Disease

Snir, J. A., Suchý, M., Lawrence, K. S., Hudson, R. H. E., Pasternak, S., & Bartha, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150123 · Cited by 12 · see citing works

Neurodegenerative biomarkers and inflammation in patients with propionic and methylmalonic acidemias: effect of L-carnitine treatment

dos Reis, B. G., Becker, G. S., Marchetti, D. P., Coelho, D. D. M., Sitta, Â., Wajner, M., & Vargas, C. R. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01475-9 · Cited by 11 · see citing works

An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer’s Disease Mouse Model

Snir, J. A., Suchý, M., Bindseil, G. A., Kovacs, M. S., Chronik, B. A., Hudson, R. H. E., Pasternak, S., & Bartha, R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170115 · Cited by 10 · see citing works

Some Remarks on Biological Markers of Alzheimer’s Disease

Robles, A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00011-6 · Cited by 9 · see citing works

Serum Cathepsin D Is a Potential Biomarker for Alzheimer’s Disease Dementia and Cognitive Decline

Chai, Y. L., Liang, N. H. P., Chong, J. R., Venketasubramanian, N., Tan, B. Y., Hilal, S., Chen, C., & Lai, M. K. P. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220852 · Cited by 9 · see citing works

Correlative cryo-soft X-ray tomography and cryo-structured illumination microscopy reveal changes to lysosomes in amyloid-β-treated neurons

Marshall, K. E., Mengham, K., Spink, M. C., Vania, L., Pollard, H. J., Darrow, M. C., Duke, E., Harkiolaki, M., & Serpell, L. C. (2024) · Structure · doi:10.1016/j.str.2024.02.010 · Cited by 8 · see citing works

Origin of α-mannosidase activity in CSF

Tasegian, A., Paciotti, S., Ceccarini, M. R., Codini, M., Moors, T. E., Chiasserini, D., Albi, E., WINCHESTER, B. G., van de Berg, W. D. J., Parnetti, L., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.03.016 · Cited by 8 · see citing works

Limited proteolytic processing of the mature form of cathepsin D in human and mouse brain: Postmortem stability of enzyme structure and activity

Compaine, A. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00020-9 · Cited by 8 · see citing works

Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia

Swift, I. J., Sjödin, S., Gobom, J., Brinkmalm, A., Blennow, K., Zetterberg, H., Rohrer, J. D., & Sogorb‐Esteve, A. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12063-9 · Cited by 6 · see citing works

Mild Cognitive Impairment

Kluger, A., Golomb, J. B., & Ferris, S. H. (2003) · doi:10.1002/9780470752340.ch25 · Cited by 6 · see citing works

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry

Lázaro, S. P., Barrio, T., Bravo, S. B., Sevilla, E., Otero, A., Chantada‐Vázquez, M. D. P., Martín‐Burriel, I., Requena, J. R., Badiola, J. J., & Bolea, R. (2024) · Veterinary Quarterly · doi:10.1080/01652176.2024.2424837 · Cited by 4 · see citing works

Single-Column Purification of Syncephapepsin—An Aspartic Proteinase fromSyncephalastrum racemosum

Ho, H.-C., Shiau, P., & Wu, S. (1998) · Protein Expression and Purification · doi:10.1006/prep.1997.0842 · Cited by 4 · see citing works

Aktuelle klinisch-neurochemische Diagnostik der Alzheimer-Krankheit/Current Clinical Neurochemical Diagnosis of Alzheimer’s Disease

Rösler, N., Wichart, I., & Jellinger, K. A. (2002) · Journal of Laboratory Medicine · doi:10.1515/labmed.2002.019 · Cited by 3 · see citing works

Peripheral Markers of Alzheimer’s

Percy, M. E., Andrews, D. F., & Potter, H. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_9 · Cited by 3 · see citing works

Quantitative proteomic analysis of down syndrome biomarkers in maternal serum using isobaric tags for relative and absolute quantification (iTRAQ)

Zhao, S., Liu, X., Wu, S., Zheng, Y., & Zhang, W. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1696302 · Cited by 2 · see citing works

Immunohistochemical study of microscopic globular bodies of normal human brain

Odagiri, S., Mori, F., Tanji, K., Kuroda, N., & Wakabayashi, K. (2011) · Biomedical Research · doi:10.2220/biomedres.32.337 · Cited by 2 · see citing works

Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's disease

Nixon, R. A. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90172-4 · Cited by 2 · see citing works

[Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease].

Arai, H., Satoh, K., Terajima, M., Nakagawa, T., Higuchi, M., Kosaka, Y.-I., Zhu, C.-Q., & Sasaki, H. (1996) · Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics · doi:10.3143/geriatrics.33.669 · Cited by 2 · see citing works

Alterations in the Na+/H+ Exchanger NHE6 and Glutamate Transporters may Influence Purkinje Cell Fate in ARSACS

Masson, L.-C., Kanagasabai, A. S., Toscano‐Márquez, B., Tourbina-Kolomiets, J., Charron, F. M., Watt, A. J., & McKinney, R. A. (2025) · The Cerebellum · doi:10.1007/s12311-025-01850-x · Cited by 1 · see citing works

Bridging autophagy and endolysosomal dysfunction: Role of bridging integrator 1 in Alzheimer’s disease

Duckhorn, J. C., Kim, D. K., & Huang, Y. A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00243 · Cited by 2 · see citing works

Novel Cathepsin D Inhibitors Prevent the β-Secretase-Derived Intracellular Formation of a 12 kDa Potentially Amyloidogenic Product in Human Cells

Chevallier, N., Marambaud, P., Vincent, J., Checler, F., Vizzavona, J., Fulcrand, P., Martínez, J., Baur, C.-P., Spillantini, M. G., & Goedert, M. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_11 · Cited by 1 · see citing works

Genetic Determinants of Cognitive Function and Age-Related Brain Changes

Schuur, M. (2010) · RePub (Erasmus University Rotterdam)

Rational design and synthesis of conformationally constrained inhibitors of human cathepsin D

Majer, P., Collins, J., Pan, W., Gulnik, S., Lee, A. Y., Gustchina, E., & Erickson, J. W. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46862-x_293

Review Autophagy in neurons: a review

Larsen, K. E., & Sulzer, D. L. (2002)

Cathepsin D Deficiency : Molecular and Cellular Mechanisms of Neurodegeneration

Partanen, S. (2006) · Työväentutkimus Vuosikirja

CELLULAR MECHANISMS OF NEURODEGENERATION

Partanen, S. (2006)

Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.

Cataldo, A. M., Paskevich, P. A., Kominami, E., & Nixon, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.10998 · Cited by 267 · see citing works

Changes in the activity of lysosomal cysteine proteases of plasma mononuclear and polymorphonuclear blood leukocytes in Alzheimer’s disease

Sorokina, M. G., Fomina, M. A., Petrov, D. S., & Korotkova, N. V. (2020) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2020-3-83-88

Elevated levels of cathepsin D in cerebrospinal fluid from Alzheimer disease patients

Schwagerl, A. L. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)92925-4

Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease

Nakamura, Y., Takeda, M., Suzuki, H., Hattori, H., Tada, K., Hariguchi, S., Hashimoto, S., & Nishimura, T. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90395-a · Cited by 111 · see citing works

Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system

Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., & Nixon, R. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90324-0 · Cited by 379 · see citing works